Am J Perinatol 2005; 22(7): 387-390
DOI: 10.1055/s-2005-872589
Copyright © 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Successful Perinatal Management of a Very Low Birthweight Infant with Congenital Complete Atrioventricular Block

Seiji Inoue1 , Masami Mizobuchi1 , Naoki Yoshimura2 , Masahiro Yamaguchi2 , Hideto Nakao1
  • 1Department of Neonatology, Kobe Children's Hospital Perinatal Center, Kobe, Japan
  • 2Department of Cardiothoracic Surgery, Kobe Children's Hospital Perinatal Center, Kobe, Japan
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
17. September 2005 (online)

ABSTRACT

We report a very low birthweight infant with congenital complete atrioventricular block (CCAVB) who underwent delayed implantation of a permanent pacemaker without temporary pacing. The female infant was born at 30 weeks gestation and weighed 1422 g. After birth, the infant showed respiratory failure due to pleural effusion and respiratory distress syndrome at birth. The heart rate ranged between 50 and 55 bpm. The chest x-ray demonstrated dilated heart, but echocardiogram showed good systolic ventricular function. Respiratory failure was resolved after supportive treatment without temporary pacing. Mild heart failure due to low heart rate persisted, but was successfully managed by conventional heart failure therapy combined with nasal continuous positive airway pressure. She achieved a body weight gain to 1856 g at the age of 49 days and underwent implantation of a permanent pacemaker. We conclude that it is important to determine the timing of both delivery and pacemaker implantation for successful perinatal management of infants with CCAVB.

REFERENCES

  • 1 Michaelsson M, Engle M A. Congenital complete heart block: an international study of the natural history.  Cardiovasc Clin. 1972;  4 85-101
  • 2 Kertesz N J, Fenrich A L, Friedman R A. Congenital complete atrioventricular block.  Tex Heart Inst J. 1997;  24 301-307
  • 3 Scott J S, Maddison P J, Taylor P V et al.. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block.  N Engl J Med. 1983;  309 209-212
  • 4 Bierman F Z, Baxi L, Jaffe I et al.. Fetal hydrops and congenital complete heart block: response to maternal steroid therapy.  J Pediatr. 1988;  112 646-648
  • 5 Buyon J, Roubey R, Swersky S et al.. Complete congenital heart block: risk of occurrence and therapeutic approach to prevention.  J Rheumatol. 1988;  15 1104-1108
  • 6 Matsushita H, Higashino M, Sekizuka N et al.. Successful prenatal treatment of congenital heart block with ritodrine administered transplacentally.  Arch Gynecol Obstet. 2002;  267 51-53
  • 7 Donofrio M T, Gullquist S D, Mehta I D et al.. Congenital complete heart block: fetal management protocol, review of the literature, and report of the smallest successful pacemaker implantation.  J Perinatol. 2004;  24 112-117
  • 8 Gregoratos G, Abrams J, Epstein A E et al.. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article.  J Cardiovasc Electrophysiol. 2002;  13 1183-1199
  • 9 Baratz D M, Westbrook P R, Shah P K et al.. Effect of nasal continuous positive airway pressure on cardiac output and oxygen delivery in patients with congestive heart failure.  Chest. 1992;  102 1397-1401
  • 10 Kurz H. Influence of nasopharyngeal CPAP on breathing pattern and incidence of apnoeas in preterm infants.  Biol Neonate. 1999;  76 129-133
  • 11 von Schnakenburg C, Fink C, Peuster M et al.. Permanent pacemaker implantation in a 1,445 g preterm neonate on the first day of life.  Thorac Cardiovasc Surg. 2002;  50 363-365

Masami MizobuchiM.D. Ph.D. 

Department of Neonatology, Kobe Children's Hospital Perinatal Center

1-1-1 Takakuradai, Suma, Kobe

654-0081, Japan